PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#hemostasis ×

UPDATED
Regulatorische Updates
2. Sept. 2026•1 Min. Lesezeit
Olympus Issues Recall of BiCOAG Hemostasis Probe Over Adhesive Defect
Olympus advises immediate discontinuation of BiCOAG Hemostasis Probe due to potential ceramic tip detachment.
UPDATED
Regulatorische Updates
2. Sept. 2026•1 Min. Lesezeit
Olympus Recalls BiCOAG Hemostasis Probe Over Adhesive Defect
Olympus advises immediate discontinuation of BiCOAG Hemostasis Probe due to possible adhesive shortage causing ceramic tip detachment.